Smithfield Trust’s Globus Medical GMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $10K | Hold |
130
| – | – | ﹤0.01% | 903 |
|
|
2026
Q1 | $11K | Hold |
130
| – | – | ﹤0.01% | 871 |
|
|
2025
Q4 | $11K | Hold |
130
| – | – | ﹤0.01% | 867 |
|
|
2025
Q3 | $7K | Hold |
130
| – | – | ﹤0.01% | 918 |
|
|
2025
Q2 | $8K | Hold |
130
| – | – | ﹤0.01% | 896 |
|
|
2025
Q1 | $10K | Hold |
130
| – | – | ﹤0.01% | 854 |
|
|
2024
Q4 | $11K | Hold |
130
| – | – | ﹤0.01% | 846 |
|
|
2024
Q3 | $9K | Hold |
130
| – | – | ﹤0.01% | 855 |
|
|
2024
Q2 | $9K | Hold |
130
| – | – | ﹤0.01% | 833 |
|
|
2024
Q1 | $7K | Hold |
130
| – | – | ﹤0.01% | 891 |
|
|
2023
Q4 | $7K | Hold |
130
| – | – | ﹤0.01% | 879 |
|
|
2023
Q3 | $6K | Hold |
130
| – | – | ﹤0.01% | 877 |
|
|
2023
Q2 | $8K | Hold |
130
| – | – | ﹤0.01% | 855 |
|
|
2023
Q1 | $7K | Hold |
130
| – | – | ﹤0.01% | 838 |
|
|
2022
Q4 | $10K | Hold |
130
| – | – | ﹤0.01% | 775 |
|
|
2022
Q3 | $8K | Hold |
130
| – | – | ﹤0.01% | 810 |
|
|
2022
Q2 | $7K | Hold |
130
| – | – | ﹤0.01% | 884 |
|
|
2022
Q1 | $10K | Hold |
130
| – | – | ﹤0.01% | 839 |
|
|
2021
Q4 | $9K | Hold |
130
| – | – | ﹤0.01% | 868 |
|
|
2021
Q3 | $10K | Hold |
130
| – | – | ﹤0.01% | 843 |
|
|
2021
Q2 | $10K | Hold |
130
| – | – | ﹤0.01% | 825 |
|
|
2021
Q1 | $8K | Hold |
130
| – | – | ﹤0.01% | 900 |
|
|
2020
Q4 | $8K | Hold |
130
| – | – | ﹤0.01% | 865 |
|
|
2020
Q3 | $6K | Buy |
+130
| New | +$6.71K | ﹤0.01% | 881 |
|
|
2020
Q1 | – | Sell |
-90
| Closed | -$5K | – | 964 |
|
|
2019
Q4 | $5K | Hold |
90
| – | – | ﹤0.01% | 793 |
|
|
2019
Q3 | $5K | Hold |
90
| – | – | ﹤0.01% | 828 |
|
|
2019
Q2 | $4K | Hold |
90
| – | – | ﹤0.01% | 840 |
|
|
2019
Q1 | $4K | Sell |
90
-2,540
| -97% | -$115K | ﹤0.01% | 793 |
|
|
2018
Q4 | $114K | Sell |
2,630
-370
| -12% | -$18.5K | 0.01% | 326 |
|
|
2018
Q3 | $170K | Sell |
3,000
-330
| -10% | -$17.4K | 0.02% | 310 |
|
|
2018
Q2 | $168K | Sell |
3,330
-100
| -3% | -$5.21K | 0.02% | 309 |
|
|
2018
Q1 | $171K | Buy |
3,430
+3,340
| +3,711% | +$157K | 0.02% | 304 |
|
|
2017
Q4 | $4K | Buy |
+90
| New | +$3.15K | ﹤0.01% | 887 |
|
Other funds holding GMED
JT
SC
Smithfield Trust's GMED Position: Q2 2026 in Review
Smithfield Trust held its Globus Medical (GMED) position steady in Q2 2026 at 130 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #903.
Smithfield Trust first reported a position in GMED in Q4 2017 and has held it in 33 quarters since. The position peaked at $171K in Q1 2018. 599 funds tracked by Wall St. Rank hold GMED as of Q2 2026.
- Smithfield Trust held 130 shares of Globus Medical worth $10K as of Q2 2026.
- Smithfield Trust left its Globus Medical share count unchanged in Q2 2026.
- Globus Medical made up ﹤0.01% of Smithfield Trust's portfolio in Q2 2026, its #903 holding.
- Smithfield Trust first reported a position in Globus Medical in Q4 2017 and has held it in 33 quarters since.
- Smithfield Trust's Globus Medical position peaked at $171K in Q1 2018.
- 599 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.
Based on Smithfield Trust's 13F filing for Q2 2026, filed 5 Aug 2026.